Genetic Technologies In Brief This Week: Centogene, Novacyt, T2 Biosystems, Inotiv, Oxford Nanopore, More News items for the week of July 11, 2022. Genetic Technologies Lab Gets Regulatory Approvals in US, Australia The lab has received NATA accreditation and CLIA certification, enabling the launch of the company's multi-disease risk assessment test in Australia and the US. In Brief This Week: Pathogenomix, Uniogen, Genetic Technologies, DnaNudge, Gravity Diagnostics, More News items for the week of Jan. 17, 2022. Genetic Technologies, WashU Team up to Study Breast Cancer Risk in Woman of African Descent The Australian company is working with the Institute for Public Health in St. Louis to expand the predictive capability of its GeneType breast cancer risk test. Genetic Technologies Fiscal Year 2021 Revenues Soar on COVID-19 Test Alliance Genetic Technologies recently signed an agreement to commercialize its test for assessing a COVID-19 patient's risk of severe disease in the US with Infinity Biologix. Jul 19, 2021 Genetic Technologies to Acquire DTC Genetic Test Provider EasyDNA for $4M Mar 4, 2021 Genetic Technologies Inks US Commercialization Deal for COVID-19 Risk Test With Infinity Biologix Jan 21, 2021 Genetic Technologies to Raise $6.6M in Direct Offering Dec 2, 2020 Genetic Technologies Lands Distribution Rights to Taliaz Antidepressant Drug Selection Tools Sep 2, 2020 Genetic Technologies Regains Compliance With Rules for Nasdaq Listing Jul 16, 2020 Genetic Technologies to Raise $5.1M in Direct Offering May 26, 2020 Genetic Technologies Prices $8M Public Offering Apr 20, 2020 Genetic Technologies Prices $1.4M Direct Offering Apr 1, 2020 Genetic Technologies Inks Deals to Raise A$1.8M Mar 16, 2020 Genetic Technologies Receives Nasdaq Delisting Notification May 22, 2019 Genetic Technologies Offers $1.2M in American Depositary Shares May 3, 2019 Genetic Technologies Out of Compliance With Nasdaq Listing Rules Apr 15, 2019 Genetic Technologies, TGen to Launch Genetic Tests in US Feb 1, 2019 Genetic Technologies, Cancer Centers to Study Breast Cancer Polygenic Risk Score Impact Dec 21, 2018 In Brief This Week: QuantuMDx, Molbio, Seegene, Qiagen, Epigenomics, More Aug 16, 2018 Genetic Technologies Announces Planned Chinese Joint Venture Aug 8, 2018 Genetic Technologies Inks A$20M Equity Placement Deal Jul 30, 2018 Genetic Technologies, Swisstec Ink Asian Distribution Deal Jun 19, 2018 Genetic Technologies, Swisstec Reach Deal on JV Mar 16, 2018 Genetic Technologies, University of Melbourne Partner on Breast Cancer Risk Test Load More Breaking News People in the News at Probius, Flagship Biosciences, Discovery Life Sciences, More New Products Posted to GenomeWeb: BillionToOne, Becton Dickinson, Enzo Biochem, More Stroke Risk Contributors, Treatment Targets Uncovered in Cross-Ancestry GWAS In Brief This Week: Yourgene Health, Bionano Laboratories, Caris Life Sciences, More Enzymatic RNA Synthesis Firm EnPlusOne Biosciences Launches With $12M in Seed Funding The Scan Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says. Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds. Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry. UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.